Acquisition of Antipsychotic, Anesthetic, and Muscle Relaxant Medications under CPA 2025/1428 for ULSASI for the Year 2026

This tender involves the acquisition of antipsychotic, anesthetic, and muscle relaxant medications for the Unidade Local de Saúde do Alto Sávio (ULSASI) for the year 2026, under the framework of CPA 2025/1428. The procurement aims to ensure the availability of essential medications required for various medical treatments within the healthcare facilities managed by ULSASI. Key requirements for bidders may include compliance with regulatory standards for pharmaceutical products, the ability to deliver medications within specified timelines, and adherence to quality assurance protocols. The tender is significant for the healthcare sector as it addresses the critical need for effective treatment options in mental health and anesthesia. Interested parties should prepare to demonstrate their capability to meet the specified needs and standards outlined in the tender documentation. The location of service delivery will be within the jurisdiction of ULSASI, which serves a diverse population requiring comprehensive healthcare services. This procurement process is part of a broader initiative to enhance healthcare delivery and patient outcomes through the provision of high-quality medical supplies.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 56.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.